Committee advances amendment to require copay assistance count toward patient cost-sharing; PBMs urge caution
The Senate Insurance Committee on Tuesday advanced an amended version of House Bill 1604 that would require PBMs and insurers to count payments from drug manufacturers and charities toward patients’ deductibles and out‑of‑pocket limits for narrowly defined prescription categories.
The full story
The Senate Insurance Committee on Tuesday advanced an amended version of House Bill 1604 that would require pharmacy benefit managers (PBMs) and insurers to count manufacturer and charitable payments toward a patient’s deductible and out‑of‑pocket maximum for narrowly defined prescription categories.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
or